Navigation Links
EPA announces research strategy to study nanomaterials
Date:9/29/2009

WASHINGTON The U.S. Environmental Protection Agency today outlined a new research strategy to better understand how manufactured nanomaterials may harm human health and the environment. Nanomaterials are materials that are between approximately one and 100 nanometers. A nanometer is approximately 1/100,000 the width of a human hair. These materials are currently used in hundreds of consumer products, including sunscreen, cosmetics and sports equipment.

The strategy outlines what research EPA will support over the next several years to generate information about the safe use of nanotechnology and products that contain nano-scale materials. The strategy also includes research into ways nanotechnology can be used to clean up toxic chemicals in the environment.

Nanomaterials are used in a wide variety of consumer products. For instance, because of the unusual light-absorbing properties of the zinc or titanium nanoparticles they contain, high-SPF nano sunscreens are clear rather than white. Studies show that they provide superior protection against UV radiation.

EPA's role among federal agencies is to determine the potential hazards of nanotechnology and develop approaches to reduce or minimize any risks identified. As part of the strategy, researchers are investigating widely used nanomaterials, such as carbon nanotubes, which are used in vehicles, sports equipment and electronics; and titanium dioxide, which is used in paints, cosmetics and sunscreens.

The research is being conducted in EPA's own laboratories and by grant recipients as part of a collaborative effort with other federal organizations and the international community.

EPA's research is conducted using a multidisciplinary approach that examines all aspects of nanomaterials in the environment, from their manufacture and use to their disposal or recycling. EPA's new nanotechnology Web site provides more details about the research and offers news and publications.


'/>"/>

Contact: Dale Kemery
kemery.dale@epa.gov
202-564-7839
U.S. Environmental Protection Agency
Source:Eurekalert

Related biology technology :

1. Oncolytics Biotech(R) Inc. Announces Reovirus and Cisplatin Research Supports U.S. Phase 2 Metastatic Melanoma Trial
2. MAQUET Cardiovascular Announces Leading Robotic Heart Surgeon Performs First Beating Heart Fully Endoscopic Bypass Surgery Using Miniaturized Cardiopulmonary Bypass System
3. Axial Biotech Announces Commercial Availability of SCOLISCORE(TM) AIS Prognostic Test
4. Alexandria Real Estate Equities, Inc. Announces Public Follow-on Offering of 3,000,000 Shares of Common Stock
5. Spherix Incorporated Announces Annual Shareholders Meeting Date
6. Compendia Bioscience Announces the Release of Oncomine 4 Research Edition
7. InspireMD Announces the Enrollment of the 1st Patient in the MGuard(TM) Israeli Registry. InspireMD Will Also Sponsor a Satellite Program Breakfast Meeting at the TCT Conference on September 24th 2009 in the Moscone Exhibition Center in San Francisco
8. MedShape Solutions, Inc. Announces First FDA-cleared Shape Memory PEEK Device; Closing of $10M Equity Offering
9. XRC Medical Imaging Announces Rapid Test Results
10. Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference
11. Boston Scientific Announces Release of Next-Generation iLab(R) System Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com News ... ... conditions are being pressured as of late due to the ... pain management has a dramatic impact on patient,s quality of ... development activities for identifying new forms of opioid formulations that ...
(Date:3/22/2017)... 22, 2017   VWR (NASDAQ: ... product and service solutions to laboratory and ... acquired EPL Archives, Inc., an international biorepository ... entire regulated product research, development and commercialization ... and ancillary services. EPL Archives is widely ...
(Date:3/22/2017)... ... March 21, 2017 , ... Proper glycosylation is critical for ... increase and/or decrease in antibody-dependent cellular cytotoxicity or complement-dependent cytotoxicity, there is a ... , To meet this demand, the team at SCIEX has developed a ...
(Date:3/22/2017)... ... March 21, 2017 , ... The Conference Forum has ... Summit) to be held on May 10-11, 2017, at the Colonnade Hotel in Boston, ... for Chief Medical Officer peer-to-peer learning, benchmarking and support. , “The Chief Medical Officer ...
Breaking Biology Technology:
(Date:3/6/2017)... 6, 2017 Mintigo , the ... announced Predictive Sales Coach TM , its new ... intelligence into Salesforce. This unique AI application will ... organizations with deep knowledge of their customers and ... engagement. Predictive Sales Coach extends Mintigo,s existing customer ...
(Date:3/2/2017)... March 2, 2017 Australian stem cell and ... CYP), has signed an agreement with the Monash Lung ... Biomedicine Discovery Institute and Department of Pharmacology at Monash ... further preclinical study to support the use of Cymerus™ ... Asthma is a chronic, long term ...
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ein ... wird seine erstklassige biometrische Lösung zur Iris-Erkennung ... mit X16 LTE auf dem Mobile World ... am Qualcomm-Stand in Halle 3, Stand 3E10, ... die Sicherheitsplattform Qualcomm Haven™ – eine Kombination ...
Breaking Biology News(10 mins):